
    
      Double-blind, randomized, cross-over (three periods) with two dose levels of triflusal,
      placebo-controlled.

      Interventions: treatment periods Triflusal 600 mg/d, 15 days Triflusal 900 mg/d , 15 days
      placebo, 15 days

      Washout period: 30 days
    
  